Kinetic model of progression of cutaneous melanoma population

Melanoma Research

Volumn 17, Issue 6, 2007, Pages 354-359

  Gutkowicz Krusin, Dina ^a   Rabinovitz, Harold S ^b  

^a Electro Optical Sciences Inc   (United States)

^b SKIN AND CANCER ASSOCIATES   (United States)

Author keywords

Early diagnosis; Invasive melanoma; Kinetic model; Melanoma in situ; Melanoma mortality; Melanoma progression; Melanoma treatment cost; Steady state solutions

Indexed keywords

ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER MORTALITY; COST; HISTOLOGY; HUMAN; INCIDENCE; KINETICS; MELANOMA; NON PROFIT ORGANIZATION; PHYSICIAN; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; STEADY STATE; UNITED STATES;

BIOPSY; DISEASE PROGRESSION; HUMANS; KINETICS; MATHEMATICS; MELANOMA; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; SKIN NEOPLASMS; UNITED STATES;

EID: 36049025193     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e3282f120bf     Document Type: Article

References (27)

1. Halpern AC, Lieb JA. Early melanoma diagnosis: a success story that leaves room for improvement. Curr Opin Oncol 2007; 19:109-115.
2. Sober A. Diagnosis and management of early melanoma: a consensus view. Semin Surg Oncol 1993; 9:194-197.
3. Elder D. Tumor progression, early diagnosis and prognosis of melanoma. Acta Oncol 1999; 38:535-547.
4. Guerry D, Synnestvedt M, Elder D, Schultz D. Lessons from tumor progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent. J Invest Dermatol 1993; 100:3428- 3458.
5. Abramova L, Slingluff CL, Patterson JW. Problems in the interpretation of apparent 'radial growth phase' melanomas that metastasize. J Cutan Pathol 2002; 29:407-414.
6. Haqq C, Nosrati M, Sudilovsky D, Crothers J, Khodabakhsh D, Puliam BL, et al. The gene expression signatures of melanoma progression. Proc Natl Acad Sci USA 2005; 102:6092-6097.
7. Zalaudek I, Horn M, Richtig E, Hodl S, Kerl H, Smolle J. Local recurrence in melanoma in situ: influence of sex, age, site of involvement and therapeutic modalities. Br J Dermatol 2003; 148:703-708.
8. Megahed M, Schon M, Selimovic D, Schon MP. Reliability of diagnosis of melanoma in situ. Lancet 2002; 359:1921-1922.
9. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the AJCC staging system for cutaneous melanoma. J Clin Oncol 2001; 19:3635-3648.
10. Gimotty PA, Botbyl J, Soong SJ, Guerry D. A population-based validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2005; 23:8065-8075.
11. Schmid-Wendtner MH, Baumert J, Eberle J, Plewig G, Volkenand M, Sander CA. Disease progression in patients with thin cutaneous melanomas (tumour thickness
12. Takata M, Saida T. Early cancers of the skin: clinical, histopathological, and molecular characteristics. Int J Clin Oncol 2005; 10:391-397.
13. Haass NK, Herlyn M. Normal human melanocyte homeostasis as a paradigm for understanding melanoma. J Investig Dermatol Symp Proc 2005; 10:153-163.
14. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer statistics 2006. CA Cancer J Clin 2006; 56:106-130.
15. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al. Cancer statistics 2005. CA Cancer J Clin 2005; 55:10-30.
16. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics 2004. CA Cancer J Clin 2004; 54:8-29.
17. Coory M, Baade P, Aitken J, Smithers M, McLeod GR, Ring I. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002. Cancer Causes Control 2006; 17:21-27.
18. Demierre MF, Chung C, Miller DR, Geller AC. Early detection of thick melanomas in the United States. Arch Dermatol 2005; 141:745.
19. Koh HK, Clapp RW, Barnett JM, Nannery WM, Tahan SR, Geller AC, et al. Systematic underreporting of cutaneous melanoma in Massachusetts. JAAD 1991; 24:545-550.
20. Merlino LA, Sullivan KJ, Whitaker DC, Lynch CF. The independent pathology laboratory as a reporting source for cutaneous melanoma incidence in Iowa, 1977-1994. JAAD 1997; 37:578-585.
21. Liu W, Dowling JP, Murray WK, McArthur GA, Thompson JF, Wolfe R, Kelly JW. Rate of growth in melanomas. Arch Dermatol 2006; 142:1551- 1558.
22. Losina E, Walensky RP, Geller A, Beddingfield FC, Wolf LL, Gilchrest BA, Freedberg KA. Visual screening for malignant melanoma. Arch Dermatol 2007; 143:21-28.
23. Welch HG, Woloshin S, Schwartz LM. Skin biopsy rates and incidence of melanoma: population based ecological study. BMJ 2005; 331:481.
24. Dennis LK. Analysis of the melanoma epidemic, both apparent and real. Arch Dermatol 1999; 135:275-280.
25. Beddingfield FC. The melanoma epidemic: res ipsa loquitur. Oncologist 2003; 8:459-465.
26. Elbaum M, Kopf AW, Rabinovitz HS, Langley RG, Kamino H, Mihm MC, et al. Automatic differentiation of melanoma from melanocytic nevi with multispectral digital dermoscopy: a feasibility study. JAAD 2001; 10:563-570.
27. Burroni M, Corona R, Dell'Eva G, Sera F, Bono R, Puddu P, et al. Melanoma computer-aided diagnosis: reliability and feasibility study. Clin Cancer Res 2004; 10:1881-1886.